Scientific Excellence to Serve Others

toXcel represented at HCPA Impact2022 Mid-Year Meeting

Founded in 1999, toXcel is committed to promoting and improving the safety, health, and well-being of people everywhere. We work with businesses, government agencies and communities to offer reliable scientific, analytic, technical, and regulatory services.

Headquartered in the Metropolitan Washington, DC region, with offices located across the U.S. and in the United Kingdom, toXcel brings worldwide expertise to challenging scientific issues in toxicology, environment, transportation, public health, and other domains.

toXcel News

EPA Announces Monkeypox Eligibility for Emerging Viral Pathogen Labeling

You’ve seen it in the news – Monkeypox is circulating and has made its way into the United States in a handful of cases. The WHO and CDC are monitoring this virus. On May 23, 2022, EPA activated its Emerging Viral Pathogen policy to allow qualified registrants to make claims against Monkeypox and inform customers about disinfection of this virus. Monkeypox is a Tier I, enveloped virus. EPA has recently published their List Q to help inform customers about which products are effective against Monkeypox. As a registrant, if your product qualified for List N for COVID-19 claims, also a Tier I enveloped virus, you would qualify for List Q. Please contact us for information on how and what claims you can make for your product.

 

 toXcel Attends the Recent HCPA Impact2022 Mid-Year Meeting in Washington, DC

Nelson Cornwell was present at the HCPA mid-year meeting in Washington, DC and attended expert-led sessions on issues that impact our client’s household and commercial products and registrations. Connie Welch-Dujardin and Nicole Perkinson (toXcel’s VP and Regulatory Affairs Manager, respectively) attended the sessions remotely. Emerging trends and regulatory issues were discussed, including disruptions caused by the ongoing COVID-19 pandemic. We are always keeping up to date on policies that may impact our clients and their product registrations.

 

Paula Raymond Presents at Drug-Impaired Driving Toxicology Workshop at the 2022 Lifesavers Conference

Paula Raymond recently served on a panel during the 2022 Lifesavers National Conference on Highway Safety Priorities for a workshop entitled, “One Drug, Two Drugs…Red Drugs, Blue Drugs: Testing & Toxicology Challenges.” Paula presented about upcoming state drug-impaired driving toxicology meetings that toXcel will be planning and facilitating under contract to the National Highway Traffic Safety Administration (NHTSA).

 

 toXcel awarded GSA Multiple Award Schedule (MAS) for Professional Services

The GSA MAS Professional Services Category offers federal, state, and local governments innovative solutions to their professional services needs. Learn more about toXcel’s GSA MAS Professional Services contract and how we can use this contract to meet customers’ needs.

 

Gaby Cross Serves on Women and Minority Leaders Panel at the 2022 Southern District ITE Student Leadership Summit

Gaby Cross recently participated in a Women and Minority Leaders Panel at the 2022 Southern District Institute of Transportation Engineers (ITE) Student Leadership Summit in Blacksburg, VA.   The Summit is a student-led conference to promote leadership and professional development for transportation engineering students through technical and professional presentations hosted by invited industry speakers and extensive student-industry networking. Virginia Tech hosted the Summit in collaboration with the University of Virginia.

 

Bryan Katz and Pamela Kryschtal involved with VDOT Study on Driver Response to Dynamic Message Sign Safety Campaign Messages

Bryan Katz and Pamela Kryschtal were part of a Virginia Transportation Research Council Team that conducted a study for the Virginia Department of Transportation (VDOT) to examine the effectiveness of non-traditional safety messages posted to dynamic message signs on roadways. These types of messages, such as, “Be on Santa’s Nice List – Drive Politely” and “Don’t be Tricked – DUIs are no Treat”  are meant to catch drivers’ attention. The study found that the signs are effective. Messages about distracted driving and driving without a  seat belt, messages meant to provoke a negative emotion, and messages using statistics are perceived to most likely change driver behavior. Read the final report and an NPR article about the study.

 

Prenatal developmental toxicity studies on fumes from oxidised asphalt (OA) 

Chris McAlinden co-authored an article in the June 2021 issue of Reproductive Toxicology, studying the effects of fumes from oxidised asphalt on fetal development. Oxidised asphalt is manufactured in large quantities and mainly applied in water proofing, sealants, joint fillings, roofing applications and roofing products, such as shingles. The aim of this study was to generate hazard data, in particular prenatal developmental toxicity data, required by the European REACH legislation for substances manufactured or imported in quantities greater than 100 tons/year, that could be subsequently used for risk assessment and securing safe use of the substance which is the key focus of REACH.

 

toXcel Included on Team Granted Eligibility for Federal Research Projects Aimed at Improving Emerging Vehicle Electronics Technologies

toXcel is proud to be part of a team led by the Transportation Research Center Inc. (TRC Inc.) that has been granted eligibility by the National Highway Traffic Safety Administration (NHTSA) to compete for research projects aimed at reducing crashes by evaluating how vehicle electronic subsystems can affect vehicle safety risk and what countermeasures can minimize that risk. Read more about this important work.

 

The Latest QSAR Capabilities

toXcel is pleased to announce that we now have a contract with Leadscope Inc. which enables us to offer a number of QSAR Toxicity Prediction models including impurity assessment according to ICH M7.  Please reach out to Christine McAlinden for details.

 

in vitro Toxicology Updates

Chris McAlinden participated in the ‘Applied in vitro toxicology course’ jointly organised by the European Society of Toxicology In Vitro (ESTIV) and the American Society for Cellular and Computational Toxicology (ASCCT) – the course covered subjects pertinent to current regulatory, screening and investigative in vitro toxicology issues, as well as practical laboratory examples.  This experience will  contribute to the guidance we are able to provide for our clients regarding the use and acceptance of in vitro methods for investigative and regulatory purposes.